Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherr

Showing results (181-190 of 245) with videos related to

Pageof 25
Sort By:
Diabetes Technology & Therapeutics|July 1, 2025
Registration and Real-Life Studies on Automated Insulin Delivery SystemsHalis Kaan Akturk, Sue A Brown, Roy W Beck, et al.
Diabetes Care|May 22, 2016
Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and LiraglutideJennifer L Sherr, Neha S Patel, Camille I Michaud, et al.
Journal of Diabetes and Its Complications|August 20, 2018
Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registryViral N Shah, Mengdi Wu, Sarit Polsky, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Registration and Real-Life Studies on Automated Insulin Delivery SystemsHalis Kaan Akturk, Sue A Brown, Roy W Beck, et al.
HIV Medicine|July 8, 2016
Age, time living with diagnosed HIV infection, and self-rated healthJ A McGowan, L Sherr, A J Rodger, et al.
Diabetes Care|January 31, 2024
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional SurveyJennifer L Sherr, Lori M Laffel, Jingwen Liu, et al.
Diabetes Care|December 19, 2024
Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery MethodLori M Laffel, Jennifer L Sherr, Jingwen Liu, et al.
Journal of Cancer Research and Therapeutics|May 19, 2010
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resectionA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Brachytherapy|October 24, 2009
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective studyA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Diabetes Technology & Therapeutics|January 26, 2024
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod<sup>®</sup> 5 Automated Insulin Delivery SystemDaniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, et al.
Pageof 25

Showing results (181-190 of 245) with videos related to

Sort By:
Pageof 25
Diabetes Technology & Therapeutics|July 1, 2025
Registration and Real-Life Studies on Automated Insulin Delivery SystemsHalis Kaan Akturk, Sue A Brown, Roy W Beck, et al.
Diabetes Care|May 22, 2016
Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and LiraglutideJennifer L Sherr, Neha S Patel, Camille I Michaud, et al.
Journal of Diabetes and Its Complications|August 20, 2018
Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registryViral N Shah, Mengdi Wu, Sarit Polsky, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Registration and Real-Life Studies on Automated Insulin Delivery SystemsHalis Kaan Akturk, Sue A Brown, Roy W Beck, et al.
HIV Medicine|July 8, 2016
Age, time living with diagnosed HIV infection, and self-rated healthJ A McGowan, L Sherr, A J Rodger, et al.
Diabetes Care|January 31, 2024
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional SurveyJennifer L Sherr, Lori M Laffel, Jingwen Liu, et al.
Diabetes Care|December 19, 2024
Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery MethodLori M Laffel, Jennifer L Sherr, Jingwen Liu, et al.
Journal of Cancer Research and Therapeutics|May 19, 2010
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resectionA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Brachytherapy|October 24, 2009
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective studyA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Diabetes Technology & Therapeutics|January 26, 2024
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod<sup>®</sup> 5 Automated Insulin Delivery SystemDaniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, et al.
Pageof 25